Clinical Trials Directory

Trials / Conditions / Alzheimer Disease (AD)

Alzheimer Disease (AD)

40 registered clinical trials studyying Alzheimer Disease (AD)25 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingTributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain
NCT06797817
Universidad de AlmeriaPhase 3
Not Yet RecruitingImproving Dementia Care in Primary Practice
NCT07526480
Thomas Jefferson UniversityN/A
Not Yet RecruitingEfficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice
NCT07505095
Second Affiliated Hospital, School of Medicine, Zhejiang University
RecruitingPredicting Pre-dementia
NCT07516119
Prevention Research Consortium Corp.
RecruitingBrain NAD in Alzheimer's Disease
NCT07127510
Florida Atlantic University
Not Yet RecruitingGeneration of Synthetic [18F]FDG PET From Early-Phase Amyloid PET in Alzheimer's Disease
NCT07431255
IRCCS San Raffaele
Not Yet RecruitingBioMIND (Biomarkers for the Molecular Identification of Neurodegenerative Dementia) - Improving Access to Alzh
NCT07422038
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Not Yet RecruitingEffectiveness of Genistein in Mild Cognitive Impairment
NCT07385937
Universidad Católica San Antonio de MurciaN/A
Not Yet RecruitingImproved Treatment and Monitoring of Alzheimer's Disease
NCT07135245
Rune Skovgaard RasmussenPhase 2
RecruitingLEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
NCT07234695
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauPhase 3
Not Yet RecruitingUnderstanding the Lived Experience and Bereavement of Caregivers of People With Alzheimer's Disease
NCT07251738
Universidad Rey Juan Carlos
Not Yet RecruitingDUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau
NCT07142278
Nuravax, Inc.Phase 1
RecruitingDaridorexant for Alzheimer Disease Prevention
NCT07213349
Douglas Mental Health University InstitutePhase 2
Not Yet RecruitingSleep Stimulation to Enhance Waste Clearance in the Brain
NCT07051239
Erasme University HospitalN/A
Not Yet RecruitingTherapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Research
NCT07152418
Second Affiliated Hospital, School of Medicine, Zhejiang University
Not Yet RecruitingAβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease
NCT07114224
Xijing HospitalN/A
CompletedEstablishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay
NCT07099001
Qure Healthcare, LLCN/A
RecruitingIntravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease
NCT07208344
Anhui Provincial HospitalEARLY_Phase 1
RecruitingAlzheimer's Disease Treated With Vagus Nerve Stimulation
NCT06923007
Beijing Municipal Administration of HospitalsN/A
RecruitingImpact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk:
NCT07146412
HudsonAlpha Institute for BiotechnologyN/A
Active Not RecruitingArlington Longitudinal Optimal Healthy Aging Study (ALOHA)
NCT07180147
Marymount University
RecruitingSilkworm Pupa Powder Improves Dementia.
NCT06898476
Zhejiang Provincial Tongde HospitalN/A
Active Not RecruitingUse of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alz
NCT07091747
Federal University of Latin American IntegrationPhase 1 / Phase 2
Not Yet RecruitingA Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients with Alzheimer's Disease.
NCT06770309
Yanbu KeN/A
Enrolling By InvitationREAl World Dementia OUTcomes: Observational Study
NCT07238049
University of Oxford
Enrolling By InvitationA Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients
NCT07287852
Hadassah Medical OrganizationPhase 2
CompletedMIND Diet in Relation to Malnutrition and Depression in AD
NCT07163923
Abant Izzet Baysal University
CompletedPhase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine
NCT06831812
Nuravax, Inc.Phase 1
RecruitingSafety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
NCT05395624
Ashvattha Therapeutics, Inc.Phase 1 / Phase 2
CompletedImpact of Musical Therapeutic Intervention on Depression in Dementia Patients and Caregiver Burden
NCT07069530
Florida SouthWestern State CollegeN/A
CompletedNasal Protollin in Early Symptomatic Alzheimer's Disease
NCT07187141
Brigham and Women's HospitalPhase 1
CompletedA Study Evaluating the Efficiency and Safety for the VGuard Device in Alzheimer's Disease.
NCT06620640
Neuromedical Sp. z o.o.N/A
CompletedEvaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal
NCT04566003
Genentech, Inc.Phase 1
WithdrawnBiomarkers in Neurodegenerative Diseases
NCT04055532
University of Minnesota
SuspendedA Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
NCT04031469
ProgenaBiome
CompletedEffects on the Olfactory Epithelium and the Olfactory Nerve From Exposure to Diesel Exhaust
NCT07237958
Umeå UniversityN/A
TerminatedCombined Effect of tDCS and Motor or Cognitive Activity in Patients With Alzheimer's Disease
NCT06619795
Universita di VeronaN/A
CompletedA Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease
NCT03518073
Eli Lilly and CompanyPhase 2
CompletedADDIA Proof-of-Performance Clinical Study
NCT03030586
Amoneta Diagnostics SAS
RecruitingComprehensive Assessment of Neurodegeneration and Dementia
NCT03402919
McGill University